The U.S. Food and Drug Administration (FDA) announced on the 13th of last month (local time) that it has approved the blood ...
Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study This ...